| Ibrutinib resistance in chronic lymphocytic leukemia RR Furman, S Cheng, P Lu, M Setty, AR Perez, A Guo, J Racchumi, G Xu, ... New England Journal of Medicine 370 (24), 2352-2354, 2014 | 353 | 2014 |
| BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity S Cheng, J Ma, A Guo, P Lu, JP Leonard, M Coleman, M Liu, JJ Buggy, ... Leukemia 28 (3), 649-657, 2014 | 218 | 2014 |
| Functional characterization of BTKC481S mutation that confers ibrutinib resistance: exploration of alternative kinase inhibitors S Cheng, A Guo, P Lu, J Ma, M Coleman, YL Wang Leukemia 29 (4), 895-900, 2015 | 177 | 2015 |
| SYK inhibition and response prediction in diffuse large B-cell lymphoma S Cheng, G Coffey, XH Zhang, R Shaknovich, Z Song, P Lu, A Pandey, ... Blood, The Journal of the American Society of Hematology 118 (24), 6342-6352, 2011 | 120 | 2011 |
| NF-κB factor c-Rel mediates neuroprotection elicited by mGlu5 receptor agonists against amyloid β-peptide toxicity M Pizzi, I Sarnico, F Boroni, M Benarese, N Steimberg, G Mazzoleni, ... Cell Death & Differentiation 12 (7), 761-772; A Corrigendum on p.1362, 2005/9, 2005 | 118 | 2005 |
| Characterization of ibrutinib‐sensitive and‐resistant mantle lymphoma cells J Ma, P Lu, A Guo, S Cheng, H Zong, P Martin, M Coleman, YL Wang British journal of haematology 166 (6), 849-861, 2014 | 101 | 2014 |
| c‐Rel regulation of the cell cycle in primary mouse B lymphocytes CY Hsia, S Cheng, AM Owyang, SF Dowdy, HC Liou International immunology 14 (8), 905-916, 2002 | 91 | 2002 |
| Cyclin E and Bcl-xL cooperatively induce cell cycle progression in c-Rel−/− B cells S Cheng, CY Hsia, G Leone, HC Liou Oncogene 22 (52), 8472-8486, 2003 | 81 | 2003 |
| Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p18INK4c and p27Kip1 X Huang, M Di Liberto, AF Cunningham, L Kang, S Cheng, S Ely, H Liou, ... Proceedings of the National Academy of Sciences 101 (51), 17789-17794, 2004 | 70 | 2004 |
| NF-kB inhibitor blocks B cell development at two checkpoints B Feng, S Cheng, WS Pear, HC Liou Medical immunology 3, 1-16, 2004 | 66 | 2004 |
| NF-κB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival B Feng, S Cheng, CY Hsia, LB King, JG Monroe, HC Liou Cellular immunology 232 (1-2), 9-20, 2004 | 59 | 2004 |
| BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten S Cheng, CY Hsia, B Feng, ML Liou, X Fang, PP Pandolfi, HC Liou Cell research 19 (2), 196-207, 2009 | 54 | 2009 |
| C-type lectin OCILRP2/Clr-g and its ligand NKRP1f costimulate T cell proliferation and IL-2 production W Tian, R Nunez, S Cheng, Y Ding, J Tumang, C Lyddane, C Roman, ... Cellular immunology 234 (1), 39-53, 2005 | 52 | 2005 |
| A single residual replacement improves the folding and stability of recombinant cassava hydroxynitrile lyase in E. coli G Yan, S Cheng, G Zhao, S Wu, Y Liu, W Sun Biotechnology letters 25 (13), 1041-1047, 2003 | 30 | 2003 |
| Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL S Cheng, G Inghirami, S Cheng, W Tam Journal of hematology & oncology 11, 1-12, 2018 | 29 | 2018 |
| Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking S Cheng, W Zhang, G Inghirami, W Tam Elife 10, e66395, 2021 | 21 | 2021 |
| Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia M Sugita, DC Wilkes, R Bareja, KW Eng, S Nataraj, RA Jimenez-Flores, ... NPJ precision oncology 5 (1), 44, 2021 | 21 | 2021 |
| Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2+ diffuse large B-cell lymphomas Y Shen, J Zhou, K Nie, S Cheng, Z Chen, W Wang, W Wei, D Jiang, ... Blood, The Journal of the American Society of Hematology 139 (1), 73-86, 2022 | 17 | 2022 |
| Methods and compositions for targeting c-Rel H Liou, W Tian, S Cheng, CY Hsia, A Owyang, JJ Hsu US Patent App. 12/226,128, 2010 | 15 | 2010 |
| A novel JAK1 mutant breast implant-associated anaplastic large cell lymphoma patient-derived xenograft fostering pre-clinical discoveries D Fiore, LV Cappelli, P Zumbo, JM Phillips, Z Liu, S Cheng, L Yoffe, ... Cancers 12 (6), 1603, 2020 | 14 | 2020 |
